Kenny MacMillan

BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemicaland biologic molecules, downstream processing, MPEG production, and conjugation chemistry.BioVectra was founded on 1970 and is based in Charlottetown, Canada.